Actively Recruiting
PRospectIve ObseRvatIonal mulTicenter Study of Patients With Arterial hYpertension and CKD in the Population of Russia
Led by AstraZeneca · Updated on 2025-06-05
10000
Participants Needed
30
Research Sites
93 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a multi-centre, non-interventional, observational, prospective study with retrospective analysis. The main purpose of the study is to describe the rate of CKD diagnosis in patients with AH and CKD markers. This study will include 10 000 adult outpatients with arterial hypertension, who have one or more Chronic Kidney Disease laboratory markers (without recorded CKD diagnosis prior to enrolment) and have no diabetes mellitus or symptomatic chronic heart failure, who are monitored and treated by cardiologists or internal medicine specialists in approximately 50 outpatient sites in about 20 regions in Russia. This observational study does not provide for any diagnostic and therapeutic procedures other than those used in routine practice.
CONDITIONS
Official Title
PRospectIve ObseRvatIonal mulTicenter Study of Patients With Arterial hYpertension and CKD in the Population of Russia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female participants aged 18 years or older at the time of signing the informed consent form
- Signed and dated written informed consent before joining the study
- Established diagnosis of essential arterial hypertension according to Russian clinical guidelines, with office systolic blood pressure 40 mmHg and/or diastolic blood pressure 90 mmHg measured on two visits
- Presence of laboratory markers of CKD (eGFR < 60 ml/min/1.73 m2 and/or albuminuria/proteinuria) measured within 12 months prior to enrollment
- No recorded diagnosis of CKD in medical documents before enrollment
You will not qualify if you...
- Diagnosis of symptomatic chronic heart failure (NYHA class II-IV) recorded in medical documents
- Diagnosis of diabetes mellitus (type 1 or type 2) recorded in medical documents
- Diagnosis of secondary arterial hypertension
- Participation in any randomized controlled trial within 3 months before or during this study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 30 locations
1
Research Site
Aramil, Russia
Actively Recruiting
2
Research Site
Chelyabinsk, Russia
Actively Recruiting
3
Research Site
Irkutsk, Russia
Actively Recruiting
4
Research Site
Kaluga, Russia
Actively Recruiting
5
Research Site
Kazan', Russia
Actively Recruiting
6
Research Site
Kemerovo, Russia
Actively Recruiting
7
Research Site
Krasnodar, Russia
Actively Recruiting
8
Research Site
Krasnoyarsk, Russia
Actively Recruiting
9
Research Site
Moscow, Russia
Actively Recruiting
10
Research Site
Nizhny Novgorod, Russia
Completed
11
Research Site
Novosibirsk, Russia
Actively Recruiting
12
Research Site
Odintsovo, Russia
Actively Recruiting
13
Research Site
Omsk, Russia
Actively Recruiting
14
Research Site
Penza, Russia
Actively Recruiting
15
Research Site
Perm, Russia
Actively Recruiting
16
Research Site
Reutov, Russia
Actively Recruiting
17
Research Site
Rostov-on-Don, Russia
Actively Recruiting
18
Research Site
Ryazan, Russia
Actively Recruiting
19
Research Site
Saint Petersburg, Russia
Actively Recruiting
20
Research Site
Samara, Russia
Actively Recruiting
21
Research Site
Stavropol, Russia
Actively Recruiting
22
Research Site
Tomsk, Russia
Actively Recruiting
23
Research Site
Tula, Russia
Actively Recruiting
24
Research Site
Ufa, Russia
Actively Recruiting
25
Research Site
Ulan-Ude, Russia
Actively Recruiting
26
Research Site
Volgograd, Russia
Actively Recruiting
27
Research Site
Vologda, Russia
Actively Recruiting
28
Research Site
Voronezh, Russia
Actively Recruiting
29
Research Site
Yaroslavl, Russia
Actively Recruiting
30
Research Site
Yekaterinburg, Russia
Actively Recruiting
Research Team
A
AstraZeneca Clinical Study Information Center
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here